Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Relay Therapeutics Inc
(NQ:
RLAY
)
6.370
+0.220 (+3.58%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Relay Therapeutics Inc
< Previous
1
2
3
4
5
Next >
Clinical-Stage BioTech Drug Stocks Portfolio Went Down 9% Last Week
April 23, 2024
A look at the 10 clinical-stage AI-powered and psychedelic compound-based small-cap drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio, their stock performances last week and...
Via
Talk Markets
12 Health Care Stocks Moving In Wednesday's After-Market Session
April 10, 2024
Via
Benzinga
AI Surge Ending: Only One Category Was Up This Week
April 06, 2024
Six of the 7 categories we cover dropped this week, compared with 3 in March. The data clearly indicates that the surge in this sector is stalling or perhaps is even over.
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
3 Precision Medicine Stocks That Could Benefit From the Industry’s Rise
March 15, 2024
Dive into the potential of precision medicine stocks poised to revolutionize healthcare and offer substantial growth opportunities.
Via
InvestorPlace
Relay Therapeutics: Q4 Earnings Insights
February 22, 2024
Via
Benzinga
Relay Therapeutics's Earnings: A Preview
February 21, 2024
Via
Benzinga
Relay Therapeutics's Earnings Outlook
November 01, 2023
Via
Benzinga
Earnings Outlook For Relay Therapeutics
August 07, 2023
Via
Benzinga
11 Analysts Have This to Say About Relay Therapeutics
June 09, 2023
Via
Benzinga
AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD
March 04, 2024
Grand View Research says the global
Via
Talk Markets
AI-Powered Drug Discovery Stocks Index Up 18% Last Week, Led By BioXcel Therapeutics
February 19, 2024
The AI-powered drug discovery market is projected to grow at a 30% CAGR between now and 2030, with annual sales in excess of $50 billion anticipated. An AI drug discovery revolution is underway.
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
The 7 Best Penny Stocks for 200% Returns
February 06, 2024
Penny stocks often possess significant upside and these are no different with 200% returns expected by analysts.
Via
InvestorPlace
AI-Focused Drug Discovery Stocks Index Up 26% In December
December 29, 2023
With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds massive potential to increase the accessibility of drugs and to treat presently incurable conditions.
Via
Talk Markets
AI-Focused Drug Discovery Stocks Index Up 10.6% Last Week
December 17, 2023
A new study concludes that the AI method of drug discovery is up to 250 times more efficient than the traditional method.
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Relay Therapeutics: Q1 Earnings Insights
May 04, 2023
Via
Benzinga
Earnings Outlook For Relay Therapeutics
May 03, 2023
Via
Benzinga
What 11 Analyst Ratings Have To Say About Relay Therapeutics
April 20, 2023
Via
Benzinga
Earnings Scheduled For February 22, 2024
February 22, 2024
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 13, 2023
Via
Benzinga
HC Wainwright & Co. Maintains Buy Rating for Relay Therapeutics: Here's What You Need To Know
December 11, 2023
Via
Benzinga
The 10 Stocks Using AI To Develop New Drugs Were Up 4%, On Average, Last Week
December 11, 2023
If, as Morgan Stanley postulates, a $50 billion AI drug discovery revolution is underway, here are 10 publicly-traded micro- and small-cap clinical stage pharma companies that are embracing AI to...
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Micro/Small Cap Companies Using AI In Drug Discovery Up 35% In November
December 06, 2023
The AI method is up to 250 times more efficient than the traditional method of drug discovery. reducing timelines for drug discovery, increasing accuracy of efficacy and safety predictions.
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
AI Alert: 3 Healthcare Stocks That Are Investing in Artificial Intelligence
November 09, 2023
We’re still in the initial stages of a massively disruptive artificial intelligence (AI) boom that's greatly impacting healthcare.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Earnings Scheduled For November 2, 2023
November 02, 2023
Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
October 12, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
September 19, 2023
During Tuesday's session, 275 companies made new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
September 26, 2023
On Tuesday, 386 stocks made new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
September 07, 2023
On Thursday, 283 companies set new 52-week lows.
Via
Benzinga
InMode, Daktronics, Domino's Pizza And Other Big Stocks Moving Higher On Wednesday
July 12, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 250 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Looking To Invest In Artificial Intelligence? Consider Evogene And Its Five Subsidiaries
April 27, 2023
Evogene employs an artificial intelligence platform for decoding plant phenotypes and microbial genomes. Consider its' research agenda, applications, and at-the-market products. The set-up may present...
Via
Talk Markets
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.